Further to DrugAlert volume 872, HPS Pharmacies wish to give notice that all manufacturers are continuing to experience a supply interruption for nizatidine capsules as follows:
|Product||ARTG||Expected date of return|
|Nizac® 150mg||284129||Late October 2023|
|Tacidine® 150mg||94204||End July 2023|
|Tazac® 150mg||284130||Mid-December 2023|
|Nizac® 300mg||96963||Late October 2023|
|Tacidine® 300mg||94205||Mid-August 2023|
|Tazac® 300mg||49326||Late October 2023|
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates